Abstract Details
Madelynne Olexa
PRESENTER |
Miss Olexa has nothing to disclose. |
Yelyzaveta Begunova | Miss Begunova has nothing to disclose. |
David Bartolome (Yale University School of Medicine) | Mr. Bartolome has nothing to disclose. |
Teng J. Peng, MD (University of Florida) | Dr. Peng has nothing to disclose. |
Charles Matouk | No disclosure on file |
Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
Nils Petersen, MD (Yale University) | Dr. Petersen has received research support from NIH. |